再探:成人创伤性脑损伤治疗性低温的系统评价
该系统评价检索2011年1月1日至2018年1月26日的Cochrane Central Register of Controlled Trial、MEDLINE、PubMed和EMBASE,纳入22项随机对照试验共2346例成人闭合性颅脑创伤患者。低偏倚风险随机对照试验显示治疗性低温组死亡率显著更高(风险比1.37,95%CI 1.04-1.79,P=0.02),而高偏倚风险随机对照试验显示相反结果(对照组死亡率更高,风险比0.70,95%CI 0.60-0.82,P<0.00001)。总体而言,高质量研究显示死亡率、不良结局或新发肺炎无显著差异,且该综述提示体温控制在创伤性脑损伤管理中有一席之地。
要点
- 低偏倚风险随机对照试验中,治疗性低温组死亡率显著高于对照组(风险比1.37,95%CI 1.04-1.79,P=0.02)。
- 高偏倚风险随机对照试验显示对照组死亡率更高(风险比0.70,95%CI 0.60-0.82,P<0.00001),与低偏倚风险研究方向相反。
- 高质量研究显示治疗性低温与对照组在死亡率、不良结局或新发肺炎方面无显著差异。
- 该综述提示体温控制在创伤性脑损伤管理中有一席之地。
- 共纳入22项随机对照试验、2346例成人急性闭合性颅脑创伤患者。
适用人群与场景
- 成人创伤性脑损伤患者,仅限急性闭合性颅脑创伤后 sustain 的损伤。
- 仅纳入英文发表的外国文献。
研究设计与关键结果
- 研究类型:随机对照试验的系统评价,检索2011年1月1日至2018年1月26日的Cochrane Central Register of Controlled Trial、MEDLINE、PubMed和EMBASE,共纳入22项研究、2346例患者。
- 低偏倚风险随机对照试验显示治疗性低温组死亡率显著更高(风险比1.37,95%CI 1.04-1.79,P=0.02)。
- 高偏倚风险随机对照试验显示对照组死亡率更高(风险比0.70,95%CI 0.60-0.82,P<0.00001)。
- 高质量研究显示死亡率、不良结局或新发肺炎无显著差异。
证据类型、等级与局限
- 证据类型:随机对照试验的系统评价,采用Cochrane Collaboration偏倚风险评估工具,使用Mantel-Haenszel估计器合并风险比及95%CI。
- 局限:原文未报告局限性。
对床旁实践的改变
- 高质量随机对照试验显示治疗性低温在死亡率、不良结局或新发肺炎方面无显著差异,不支持将其作为改善这些结局的常规措施。
- 该综述提示体温控制在创伤性脑损伤管理中有一席之地。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Therapeutic hypothermia has been of topical interest for many years and with the publication of two international, multicenter randomized controlled trials, the evidence base now needs updating. The aim of this systematic review of randomized controlled trials is to assess the efficacy of therapeutic hypothermia in adult traumatic brain injury focusing on mortality, poor outcomes, and new pneumonia.
DATA SOURCES: The following databases were searched from January 1, 2011, to January 26, 2018: Cochrane Central Register of Controlled Trial, MEDLINE, PubMed, and EMBASE.
STUDY SELECTION: Only foreign articles published in the English language were included. Only articles that were randomized controlled trials investigating adult traumatic brain injury sustained following an acute, closed head injury were included. Two authors independently assessed at each stage.
DATA EXTRACTION: Quality was assessed using the Cochrane Collaboration's tool for assessing the risk of bias. All extracted data were combined using the Mantel-Haenszel estimator for pooled risk ratio with 95% CIs. p value of less than 0.05 was considered statistically significant. All statistical analyses were conducted using RevMan 5 (Cochrane Collaboration, Version 5.3, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
DATA SYNTHESIS: Twenty-two studies with 2,346 patients are included. Randomized controlled trials with a low risk of bias show significantly more mortality in the therapeutic hypothermia group (risk ratio, 1.37; 95% CI, 1.04-1.79; p = 0.02), whereas randomized controlled trials with a high risk of bias show the opposite with a higher mortality in the control group (risk ratio, 0.70; 95% CI, 0.60-0.82; p < 0.00001).
CONCLUSIONS: Overall, this review is in-keeping with the conclusions published by the most recent randomized controlled trials. High-quality studies show no significant difference in mortality, poor outcomes, or new pneumonia. In addition, this review shows a place for fever control in the management of traumatic brain injury.
参考来源
- Watson HI, Shepherd AA, Rhodes JKJ, et al. Revisited: A Systematic Review of Therapeutic Hypothermia for Adult Patients Following Traumatic Brain Injury. Crit Care Med. 2018. PMID: 29601315. doi:10.1097/CCM.0000000000003125
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。